CVS Group plc (CVSGF) Research

CVS Group plc, through its various subsidiaries, operates a comprehensive range of animal care services, including veterinary treatment, pet cremation, and online retail of pet supplies and pharmaceuticals. The company structures its diverse activities across four primary segments: its network of veterinary practices, diagnostic laboratories, crematoria, and its digital retail platform. It manages numerous animal veterinary clinics and offers complementary veterinary diagnostic support. Additionally, CVS Group provides pet cremation and clinical waste disposal solutions for veterinary establishments. Its online retail venture, Animed Direct, functions as both a dispensary and an e-commerce store, providing prescription and over-the-counter medications, pet food, and various other pet care essentials. The group further offers pet burial grounds, supplies veterinary instruments, and engages in property development. CVS Group plc maintains a significant footprint, owning 472 veterinary clinics, 3 laboratories, and 7 crematoria across the United Kingdom, the Netherlands, and the Republic of Ireland. Established in 1999, the company's main office is located in Diss, UK.

Market snapshot

Symbol
CVSGF
Price
$16.55
Day change
0.00%
Market cap
$820.6M
P/E ratio
53.16x
52-week range
14.5-17.66
Sector
Consumer Cyclical
Industry
Personal Products & Services
Next earnings
in 3 months

Recent news

  • UK's CVS Group CEO to step down after 7 years at the helm

    British veterinary services ​provider CVS Group said on Monday ‌CEO Richard Fairman plans to retire after seven years in the role.

Peer companies

  • Dr. Martens plc (DOCMF)
  • Dream International Limited (DRMMF)
  • Fiskars Oyj Abp (FKRAF)
  • HORNBACH Holding AG & Co. KGaA (HBBHF)
  • The Hongkong and Shanghai Hotels, Limited (HKSHF)
  • Magazine Luiza S.A. (MGLUY)
  • MIPS AB (publ) (MPZAF)
  • Pets at Home Group Plc (PAHGF)

Open CVS Group plc (CVSGF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.